November 9, 2017: MCG & Invariant's Ben Klein discuss current healthcare policy topics such as using telemedicine to address the Opioid Crisis, the Chronic (CHRONIC) Care Act of 2017, CHIP Reauthorization, and the future of Obamacare.

November 9, 2017: MCG &amp; Invariant's Ben Klein discuss current healthcare policy topics such as using telemedicine to address the Opioid Crisis, the Chronic (CHRONIC) Care Act of 2017, CHIP Reauthorization, and the future of Obamacare.

MCG Podcast: Opioids, the CHRONIC Care Act, & CHIP Reauthorization

MCG Health, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in their patient-centered care decisions. Our artificial intelligence and technology solutions, infused with objective clinical expertise, enable our clients to prioritize and simplify their work. MCG’s world-class customer service ensures that our clients maximize the benefits of licensing MCG solutions – demonstrating improved financial and clinical outcomes.

Share MCG Podcast: Opioids, the CHRONIC Care Act, & CHIP Reauthorization

Sign up to save your podcasts

MCG Podcast: Opioids, the CHRONIC Care Act, & CHIP Reauthorization

MCG Podcast: Opioids, the CHRONIC Care Act, & CHIP Reauthorization